Caris Life Sciences announced today that the company will present at the 41st Annual J.P. Morgan Healthcare Conference, which is being held January 9-12, 2023.
| IRVING, Texas, January 4, 2023 /PRNewswire/ -- Caris Life Sciences (Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, announced today that the company will present at the 41st Annual J.P. Morgan Healthcare Conference, which is being held January 9-12, 2023 in San Francisco. Caris will present at 11:00 a.m. (PST) on Tuesday, January 10, and will provide an overview of the business and discuss recent corporate achievements that position the organization to further extend its leadership position in the market.
Caris will be represented by David D. Halbert, Founder, Chairman and Chief Executive Officer; Brian J. Brille, Vice Chairman; David Spetzler, MS, MBA, Ph.D., President and Chief Scientific Officer; Brian Lamon, Ph.D., Chief Business Officer, Head of BioPharma Business Development; Milan Radovich, Ph.D., Chief Precision Medicine Officer; Luke Power, Interim CFO and Chief Accounting Officer; and Narendra Chokshi, Corporate Vice President, Corporate Development. About Caris Life Sciences With a primary focus on cancer, Caris’ suite of market-leading molecular profiling offerings assesses DNA, RNA and proteins to reveal a molecular blueprint that helps patients, physicians and researchers better detect, diagnose and treat patients. Caris’ latest advancement, which is currently available within its Precision Oncology Alliance, is a blood-based, circulating nucleic acids sequencing (cNAS) assay that combines comprehensive molecular analysis (Whole Exome and Whole Transcriptome Sequencing from blood) and serial monitoring – making it the most powerful liquid biopsy assay ever developed. Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Denver, Tokyo, Japan and Basel, Switzerland. Caris provides services throughout the U.S., Europe, Asia and other international markets. To learn more, please visit CarisLifeSciences.com or follow us on LinkedIn. Investor Relations Contact: Corporate Development Contact: Media Contact:
SOURCE Caris Life Sciences |
View original content to download multimedia:
